Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ELVNELVN
13 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ENLIVEN THERAPEUTICS INC

NORTHERN TRUST CORP holds 440,938 shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $22.4M as of 2026-Q2. The position was increased (+18.4% shares). ELVN represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$22.4M

Current Shares

440,938

Total Value Change

+$18.4M

Total Shares Change

+244,998

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
440,938
+18.4%
$22.4M0.0%$50.75
33
2026-Q1
Increased
372,316
+5.7%
$14.6M0.0%$28.75
30
2025-Q4
Decreased
352,239
-10.7%
$5.4M0.0%$15.55
0
2025-Q3
Increased
394,452
+21.5%
$8.1M0.0%$20.30
33
2025-Q2
Decreased
324,628
-4.1%
$6.5M0.0%$20.68
0
2025-Q1
Increased
338,650
+2.2%
$6.7M0.0%$21.07
28
2024-Q4
Increased
331,500
+8.9%
$7.5M0.0%$22.39
30
2024-Q3
Increased
304,396
+33.6%
$7.8M0.0%$24.13
35
2024-Q2
Increased
227,767
+4.1%
$5.3M0.0%$23.37
28
2024-Q1
Decreased
218,758
-2.7%
$3.8M0.0%$17.59
0
2023-Q4
Increased
224,812
+15.6%
$3.1M0.0%$13.84
30
2023-Q3
Decreased
194,534
-0.7%
$2.7M0.0%$13.66
0
2023-Q2
New
195,940
-
$4M0.0%$19.49
37

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used